| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$257,701 ) |
| | 2024 | 2022 | MAJESTIC THERAPEUTICS, LLC | 5931 E FINISTERRA | TUCSON | AZ | 85750-1010 | PIMA | USA | R41CA271967 | Development of lysosome targeted therapeutics | 000 | 1 | NIH | 10/18/2023 | $0 |
| | 2024 | 2022 | MAJESTIC THERAPEUTICS, LLC | 5931 E FINISTERRA | TUCSON | AZ | 85750-1010 | PIMA | USA | R41CA271967 | Development of lysosome targeted therapeutics | 001 | 1 | NIH | 5/2/2024 | -$257,701 |
|
| Issue Date FY: 2022 ( Subtotal = $258,341 ) |
| | 2022 | 2022 | MAJESTIC THERAPEUTICS, LLC | 5931 E FINISTERRA | TUCSON | AZ | 85750-1010 | PIMA | USA | R41CA271967 | Development of lysosome targeted therapeutics | 000 | 1 | NIH | 6/22/2022 | $258,341 |
|
|
